IFX-1 is in development to treat inflammatory conditions such as hidradenitis suppurativa, ANCA-associated vasculitis, and pyoderma gangraenosum.
Source link
Related
https://i2.wp.com/higenix.com/wp-content/uploads/2020/05/AdobeStock_117669104.jpeg?fit=3733%2C2100&ssl=1
2100
3733
Steve
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png
Steve2020-05-22 23:18:182020-05-22 23:18:18Stock Alert: InflaRx NV Continues To Trend Higher
Leave a Reply
Want to join the discussion?Feel free to contribute!